5AM Ventures VI, L.P.

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 6
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Latigo Biotherapeutics, Inc.—Conversionnothing paid1,484,401 sharesAug 12, 2026Latigo Biotherapeutics, Inc.nothing paidConversion · Aug 12Conversion1,484,401Aug 12, 2026
Latigo Biotherapeutics, Inc.—Conversionnothing paid866,018 sharesAug 12, 2026Latigo Biotherapeutics, Inc.nothing paidConversion · Aug 12Conversion866,018Aug 12, 2026
Latigo Biotherapeutics, Inc.—Conversionnothing paid1,823,238 sharesAug 12, 2026Latigo Biotherapeutics, Inc.nothing paidConversion · Aug 12Conversion1,823,238Aug 12, 2026
Latigo Biotherapeutics, Inc.—Conversionnothing paid3,152,305 sharesAug 12, 2026Latigo Biotherapeutics, Inc.nothing paidConversion · Aug 12Conversion3,152,305Aug 12, 2026
Latigo Biotherapeutics, Inc.—Conversion—2,350,419 sharesAug 12, 2026Latigo Biotherapeutics, Inc.—Conversion · Aug 12Conversion2,350,419Aug 12, 2026